Search results for "4-Methylenedioxyamphetamine"

showing 10 items of 39 documents

Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4-methylendioxy-N-methylamphetamine (MDMA) in seized street drug …

2021

Amphetamine (speed), methamphetamine (crystal meth), and 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) represent the most frequently abused amphetamine-type stimulants (ATS). Differences in pharmacological potency and metabolism have been shown for the enantiomers of all three stimulants. Legal consequences in cases of drug possession may also differ according to the German law depending on the enantiomeric composition of the seized drug. Therefore, enantioselective monitoring of seized specimens is crucial for legal and forensic casework. Various kinds of samples of amphetamine (n = 143), MDMA (n = 94), and methamphetamine (n = 528) that were seized in southern Germany in 2019 and…

DrugChromatographyChemistryIllicit Drugsmedia_common.quotation_subjectN-Methyl-34-methylenedioxyamphetamineEcstasyForensic toxicologyPharmaceutical ScienceMDMAStereoisomerismMethamphetamineAnalytical ChemistryMethamphetamineChiral column chromatographyAmphetaminemedicineEnvironmental ChemistryEnantiomerAmphetamineSpectroscopymedia_commonmedicine.drugDrug testing and analysisREFERENCES
researchProduct

Detection of  9-Tetrahydrocannabinol and Amphetamine-Type Stimulants in Oral Fluid Using the Rapid Stat  Point-of-Collection Drug-Testing Device

2010

The Rapid Stat assay, a point-of-collection drug-testing device for detection of amphetamines, cannabinoids, cocaine, opiates, methadone, and benzodiazepines in oral fluid, was evaluated for cannabis and amphetamine-type stimulants. The Rapid Stat tests (n = 134) were applied by police officers in routine traffic checks. Oral fluid and blood samples were analyzed using gas chromatography-mass spectrometry (GC-MS) for Delta(9)-tetrahydrocannabinol, amphetamine, methamphetamine, methylenedioxymethamphetamine, methylenedioxyethylamphetamine, and methylenedioxyamphetamine. The comparison of GC-MS analysis of oral fluid with the Rapid Stat results for cannabis showed a sensitivity of 85%, a spec…

DrugMarijuana AbuseSalivaN-Methyl-34-methylenedioxyamphetamineHealth Toxicology and Mutagenesismedia_common.quotation_subjectmedicine.medical_treatmentAmphetamine-Related DisordersPharmacologyToxicologySensitivity and SpecificityGas Chromatography-Mass SpectrometryMethamphetamineAnalytical ChemistryPredictive Value of TestsmedicineHumansEnvironmental ChemistryFalse Positive ReactionsDronabinolSalivaAmphetamineFalse Negative Reactionsmedia_commonImmunoassayChemical Health and SafetyChromatographybiologyChemistryAmphetaminesSolid Phase ExtractionMethamphetaminebiology.organism_classificationSubstance Abuse DetectionAmphetamineCannabinoidCannabisGas chromatography–mass spectrometrymedicine.drugMethadoneJournal of Analytical Toxicology
researchProduct

Binge administration of 3,4-methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus.

2006

3,4-Methylenedioxymethamphetamine (MDMA) is a potent stimulant and hallucinogenic drug whose ability to regulate neurogenesis in the adult has not been previously investigated. We used 5'-bromo-2-deoxyuridine (BrdU) and Ki-67 as mitotic markers, and doublecortin (DCX) as a marker of immature neurons, to study proliferation, survival and maturation of adult-generated cells in the dentate gyrus (DG) of the hippocampus following binge administration of MDMA (8 injections of 5 mg/kg at 6 h intervals). The results showed that MDMA treatment did not affect cytogenesis in the DG, but significantly decreased the survival rate of cells incorporated after 2 weeks to the granular layer of the DG by ca…

HallucinogenDoublecortin Domain ProteinsMalemedicine.medical_specialtyDoublecortin ProteinCell SurvivalN-Methyl-34-methylenedioxyamphetamineHippocampusCellular and Molecular NeuroscienceInternal medicinemedicineAnimalsProgenitor cellRats WistarPharmacologyNeuronsAnalysis of VariancebiologyBehavior AnimalDentate gyrusStem CellsNeurogenesisNeuropeptidesColocalizationMDMACell DifferentiationImmunohistochemistryDoublecortinRatsEndocrinologyKi-67 Antigennervous systemBromodeoxyuridineDentate Gyrusbiology.proteinHallucinogensNeuroscienceMicrotubule-Associated Proteinsmedicine.drugNeuropharmacology
researchProduct

Neurochemical substrates of the rewarding effects of MDMA: implications for the development of pharmacotherapies to MDMA dependence.

2015

In recent years, studies with animal models of reward, such as the intracranial self-stimulation, self-administration, and conditioned place preference paradigms, have increased our knowledge on the neurochemical substrates of the rewarding effects of 3,4-methylenedioxymetamphetamine (MDMA) in rodents. However, pharmacological and neuroimaging studies with human participants are scarce. Serotonin [5-hydroxytryptamine (5-HT)], dopamine (DA), endocannabinoids, and endogenous opiates are the main neurotransmitter systems involved in the rewarding effects of MDMA in rodents, but other neurotransmitters such as glutamate, acetylcholine, adenosine, and neurotensin are also involved. The most impo…

HallucinogenSubstance-Related DisordersN-Methyl-34-methylenedioxyamphetamineBiology03 medical and health sciences0302 clinical medicineNeurochemicalRewardNeurotransmitter receptorDopamineConditioning PsychologicalmedicineAnimalsHumansNeurotransmitter metabolismPharmacologyBrainMDMAConditioned place preference030227 psychiatryReceptors NeurotransmitterPsychiatry and Mental healthHallucinogensSerotoninNeurosciencepsychological phenomena and processes030217 neurology & neurosurgerymedicine.drugBehavioural pharmacology
researchProduct

The novelty-seeking phenotype modulates the long-lasting effects of intermittent ethanol administration during adolescence.

2013

The aim of the present study was to investigate if a novelty-seeking phenotype mediates the long-lasting consequences of intermittent EtOH intoxication during adolescence. The hole board test was employed to classify adolescent mice as High- or Low-Novelty Seekers. Subsequently, animals were administered ethanol (1.25 or 2.5 g/kg) on two consecutive days at 48-h intervals over a 14-day period. Anxiety levels - measured using the elevated plus maze- spontaneous motor activity and social interaction test were studied 3 weeks later. A different set of mice underwent the same procedure, but received only the 2.5 g/kg dose of ethanol. Three weeks later, in order to induce CPP, the same animals w…

MaleAginglcsh:MedicinePoison controlSocial SciencesAnxietyToxicologychemistry.chemical_compoundMiceBehavioral NeuroscienceCocaineMedicine and Health SciencesPsychologyPublic and Occupational Healthlcsh:ScienceHole-board testMultidisciplinaryAlcohol ConsumptionBehavior AnimalMDMAPhenotypeBehavioral PharmacologyAnxietymedicine.symptomBehavioral and Social Aspects of HealthReinforcement Psychologymedicine.drugResearch Articlemedicine.medical_specialtyElevated plus mazeAdolescentmedicine.drug_classN-Methyl-34-methylenedioxyamphetamineBiologyAnxiolyticInternal medicineMental Health and PsychiatrymedicineAnimalsHumansMaze LearningNutritionPharmacologyBehaviorEthanolEthanollcsh:RNovelty seekingBiology and Life SciencesDietEndocrinologychemistryExploratory Behaviorlcsh:QClinical MedicineNeurosciencePloS one
researchProduct

Sex-dependent effects of early maternal deprivation on MDMA-induced conditioned place preference in adolescent rats: Possible neurochemical correlates

2013

Abstract The early neonatal stage constitutes a sensitive period during which exposure to adverse events can increase the risk of neuropsychiatric disorders. Maternal deprivation (MD) is a model of early life stress that induces long-term behavioural and physiological alterations, including susceptibility to different drugs of abuse. In the present study we have used the conditioned place preference (CPP) paradigm to address the influence of MD on the rewarding effects of 3,4-methylenedioxymetamphetamine (MDMA) in adolescent animals of both sexes. We have previously observed in adolescent rats that MD induces modifications in the serotonergic and endocannabinoid systems, which play a role i…

MaleAgingmedicine.medical_specialtyN-Methyl-34-methylenedioxyamphetamineConditioning ClassicalToxicologySerotonergicOpen fieldchemistry.chemical_compoundNeurochemicalCorticosteroneInternal medicinemental disordersmedicineAnimalsRats WistarBrain ChemistrySex CharacteristicsMaternal deprivationbusiness.industryMaternal DeprivationBrainMDMAConditioned place preferenceRatsEndocrinologychemistryAnesthesiaFemaleSerotoninbusinesspsychological phenomena and processesmedicine.drugToxicology
researchProduct

Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice

2010

AbstractBackgroundNumerous reports indicate that MDMA users consume other psychoactive drugs, among which cannabis is one of the most common. The aim of the present study was to evaluate, using the conditioned place preference, the effect of the cannabinoid agonist WIN 55,212-2 on the rewarding effects of MDMA in mice.MethodsIn the first experiment adolescent mice were initially conditioned with 1.25, 2.5 or 5 mg/kg of MDMA or 0.1 or 0.5 mg/kg of WIN and subsequently with both drugs. Reinstatement of the extinguished preference by priming doses was performed in the groups that showed CPP. In the second experiment, animals were conditioned with 2.5 or 5 mg/kg of MDMA and, after extinction, r…

MaleAgonistCannabinoid receptormedicine.drug_classMorpholinesN-Methyl-34-methylenedioxyamphetamineCognitive Neurosciencemedicine.medical_treatmentMice Inbred StrainsNaphthalenesPharmacologylcsh:RC346-429Extinction PsychologicalMiceBehavioral NeuroscienceSerotonin AgentsPiperidinesReceptor Cannabinoid CB1RewardRimonabantConditioning Psychologicalmental disordersmedicineAnimalsDrug Interactionslcsh:Neurology. Diseases of the nervous systemBiological PsychiatryBrain ChemistryBehavior AnimalDose-Response Relationship DrugbiologyResearchMDMAGeneral MedicineExtinction (psychology)Calcium Channel Blockersbiology.organism_classificationConditioned place preferenceBenzoxazinesNeuroprotective AgentsPyrazolesCannabinoidCannabisRimonabantPsychologypsychological phenomena and processesmedicine.drugBehavioral and Brain Functions
researchProduct

Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference

2011

Cannabis is one of the drugs most commonly consumed in combination with ecstasy (3,4-methylenedioxymethamphetamine, MDMA). Although numerous studies have attempted to further our understanding of the role of the cannabinoid system in drug abuse, few have focused on how it influences the rewarding effects of MDMA. The aim of the present study was to evaluate the role of the CB1 cannabinoid receptor in vulnerability to reinstatement of a MDMA-induced conditioned place preference (CPP). Mice were first conditioned with 5mg/kg of MDMA. Once the preference had been extinguished, a priming dose of MDMA, alone or plus the CB1 cannabinoid agonist WIN 55,212-2 (0.1 and 0.5mg/kg) or the CB1 cannabino…

MaleAgonistCannabinoid receptormedicine.drug_classMorpholinesN-Methyl-34-methylenedioxyamphetaminemedicine.medical_treatmentDrug-Seeking BehaviorClinical BiochemistryEcstasyNaphthalenesPharmacologyToxicologyBiochemistryMiceBehavioral NeuroscienceReceptor Cannabinoid CB1Conditioning Psychologicalmental disordersmedicineAnimalsBiological PsychiatryPharmacologyDose-Response Relationship DrugCannabinoidsbusiness.industrymusculoskeletal neural and ocular physiologyAntagonistMDMAEndocannabinoid systemConditioned place preferenceBenzoxazinesnervous systemlipids (amino acids peptides and proteins)Cannabinoidbusinesspsychological phenomena and processesmedicine.drugPharmacology Biochemistry and Behavior
researchProduct

Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice.

2007

Although the rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in self-administration and conditioned place preference (CPP) procedures, its addictive potential (ie, the vulnerability to relapse, measured by its ability to induce reinstatement of an extinguished response), remains poorly understood. In this study, the effects of MDMA (5, 10, and 20 mg/kg) on the acquisition, extinction and reinstatement of CPP were evaluated in mice, using two different protocols during acquisition of CPP. In the first experiment, animals were trained using a two-session/day schedule (MDMA and saline for 4 consecutive days), whereas in the second experiment, they were trai…

MaleBiogenic AminesReinforcement ScheduleN-Methyl-34-methylenedioxyamphetamineStriatumPharmacologyExtinction Psychologicalchemistry.chemical_compoundMiceRewardDopaminemental disordersmedicineAnimalsNeurotransmitterPharmacologyBrain ChemistryAnalysis of VarianceBehavior AnimalDose-Response Relationship DrugMDMAExtinction (psychology)Conditioned place preferenceRatsPsychiatry and Mental healthchemistryAnimals NewbornAnesthesiaHallucinogensConditioning OperantSerotoninAnalysis of variancePsychologypsychological phenomena and processesmedicine.drugNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
researchProduct

Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: Role of CB1 receptors

2013

Numerous reports have highlighted the role of the endocannabinoid system in the addictive potential of MDMA (3,4-methylenedioxy-methamphetamine). A previous report showed that CB1 knockout (KOCB1) mice do not acquire MDMA self-administration, despite developing conditioned place preference (CPP). This contradiction could be due to the particular procedure of place conditioning used. The present work compares MDMA-induced CPP in KOCB1 mice using unbiased and biased procedures of place conditioning. In the unbiased procedure, MDMA induced CPP and reinstatement of the extinguished preference in wild type (WT) mice, but not in KOCB1 mice. In contrast, in a biased protocol of CPP, MDMA produced …

MaleElevated plus mazeTime FactorsSubstance-Related Disordersmedicine.drug_classDopamineN-Methyl-34-methylenedioxyamphetamineNucleus accumbensPharmacologyAnxiolyticDevelopmental psychologyMiceNeurochemicalReceptor Cannabinoid CB1mental disordersmedicineAnimalsMaze LearningBiological PsychiatryMice KnockoutPharmacologyAnalysis of VarianceDose-Response Relationship DrugBrainHomovanillic AcidMDMAConditioned place preferenceDisease Models AnimalMonoamine neurotransmitternervous systemHallucinogens34-Dihydroxyphenylacetic AcidConditioning OperantSerotoninPsychologyReinforcement Psychologypsychological phenomena and processesmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct